Paper822941
Cardiotoxicity of adriamycin and related anthracyclines.
Lenaz L and 1 other. Cancer Treat Rev, 1976. Cited by 377 papers, by iCite.
Cite this record
ConductScience Library. Cardiotoxicity of adriamycin and related anthracyclines. Papers, record 822941. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/822941
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Daunorubicin | Major topic |
| Doxorubicin | Major topic |
| Heart | Major topic |
| Heart Diseases | Major topic |
| Animals | |
| Arrhythmias, Cardiac | |
| Chick Embryo | |
| Cricetinae | |
| Dogs | |
| Haplorhini | |
| Heart Conduction System | |
| Heart Failure | |
| Humans | |
| Myocardium | |
| Rabbits |
Source PubMed
Cited by65
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 377 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40225989 | Druggable upregulated proteins in EWS-FLI-driven Ewing sarcoma as emerging new therapeutic targets. | Am J Transl Res | 2025 | https://conductscience.org/library/papers/40225989 | PubMed |
| 38559280 | Cardiovascular toxicities of chemotherapies: challenging the paradigm for left ventricular ejection fraction monitoring during and after treatment. | Am Heart J Plus | 2022 | https://conductscience.org/library/papers/38559280 | PubMed |
| 35110120 | Evaluation of Cardiotoxic Effects of Anthracyclines by Tissue Doppler Imaging in Survivors of Childhood Cancer. | Turk Arch Pediatr | 2021 | https://conductscience.org/library/papers/35110120 | PubMed |
| 30756483 | Conjugate of Doxorubicin to Albumin-Binding Peptide Outperforms Aldoxorubicin. | Small | 2019 | https://conductscience.org/library/papers/30756483 | PubMed |
| 30310418 | Chemotherapy-related Cardiomyopathy. | Eur Cardiol | 2015 | https://conductscience.org/library/papers/30310418 | PubMed |
| 29615646 | Bile Acids Increase Doxorubicin Sensitivity in ABCC1-expressing Tumour Cells. | Sci Rep | 2018 | https://conductscience.org/library/papers/29615646 | PubMed |
| 27766227 | Cardioprotective Effect of Grape Seed Extract on Chronic Doxorubicin-Induced Cardiac Toxicity in Wistar Rats. | Adv Pharm Bull | 2016 | https://conductscience.org/library/papers/27766227 | PubMed |
| 25395954 | Prognostic role of troponin and natriuretic peptides as biomarkers for deterioration of left ventricular ejection fraction after chemotherapy. | Arch Med Sci | 2014 | https://conductscience.org/library/papers/25395954 | PubMed |
| 22871201 | Cardiotoxicity in childhood cancer survivors: strategies for prevention and management. | Future Cardiol | 2012 | https://conductscience.org/library/papers/22871201 | PubMed |
| 22345874 | Cardioprotective effect of curcumin against doxorubicin-induced myocardial toxicity in albino rats. | Indian J Pharmacol | 2012 | https://conductscience.org/library/papers/22345874 | PubMed |
| 21455418 | Protective role of Phyllantus niruri extract in doxorubicin-induced myocardial toxicity in rats. | Indian J Pharmacol | 2011 | https://conductscience.org/library/papers/21455418 | PubMed |
| 20495142 | Reduced in vivo high-energy phosphates precede adriamycin-induced cardiac dysfunction. | Am J Physiol Heart Circ Physiol | 2010 | https://conductscience.org/library/papers/20495142 | PubMed |
| 19194787 | Human scleral diffusion of anticancer drugs from solution and nanoparticle formulation. | Pharm Res | 2009 | https://conductscience.org/library/papers/19194787 | PubMed |
| 19133708 | Use of N-terminal pro-brain natriuretic peptide to assess left ventricular function after adjuvant doxorubicin therapy in early breast cancer patients: a prospective series. | Clin Drug Investig | 2009 | https://conductscience.org/library/papers/19133708 | PubMed |
| 18415035 | Addition of rituximab to chop does not increase the risk of cardiotoxicity in patients with non-Hodgkin's lymphoma. | Med Oncol | 2008 | https://conductscience.org/library/papers/18415035 | PubMed |
| 12085249 | A phase I dose-escalating study of DaunoXome, liposomal daunorubicin, in metastatic breast cancer. | Br J Cancer | 2002 | https://conductscience.org/library/papers/12085249 | PubMed |
| 10918429 | Cardiac systolic function before and after hematopoietic stem cell transplantation. | Bone Marrow Transplant | 2000 | https://conductscience.org/library/papers/10918429 | PubMed |
| 10789823 | Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention. | Drug Saf | 2000 | https://conductscience.org/library/papers/10789823 | PubMed |
| 10193684 | Chemoprotectants: a review of their clinical pharmacology and therapeutic efficacy. | Drugs | 1999 | https://conductscience.org/library/papers/10193684 | PubMed |
| 8692743 | Differences in lipoprotein concentration and composition modify the plasma distribution of free and liposomal annamycin. | Pharm Res | 1996 | https://conductscience.org/library/papers/8692743 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/822941
GET https://conductscience.org/api/papers/v1/822941/cited_by?page=2